FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Has released Phase 1 results for two targeted cancer candidates and widened the VRN11 trial to four countries. Also seen: Global approvals · expansion

  • Received Malaysian approval for the global Phase 1b/2 trial of VRN11. Source
  • Presented VRN11 Phase 1 results at ESMO 2026. Source

Roles often seen at this stageClinical & PV · Research & development · Regulatory affairs

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

Voronoi

A drug developer that uses its VORONOMICS platform to discover kinase inhibitors designed to reach the brain.

VRN11

Phase 1

A candidate for EGFR-mutant non-small cell lung cancer; in Phase 1, seven of eight C797S-mutant patients dosed at 160 mg or more had an objective response, and a global Phase 1b/2 trial runs in Australia, Hong Kong, Singapore and Malaysia.

VORONOMICS

Technology platform

Its in-house discovery platform for quickly finding selective, brain-penetrant development candidates.

Completion reported

Received Malaysian approval for the global Phase 1b/2 trial of VRN11, bringing the trial to four countries.

Official role guide

Voronoi careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page was found, but postings and duties were not read in this check.
Experience & requirements
Unconfirmed — Requirements were not checked on the official careers page.

Information from a role guide does not establish a current vacancy.

Sources & coverage 5

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. Voronoi ↗보로노이 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable
  2. 보로노이, VRN11 글로벌 임상 말레이시아로 확대 ↗파이낸셜뉴스 · Published 2026-09-08 · Sources checked 2026-11-18 · Original unavailable
  3. 보로노이, ESMO서 폐암 치료제 'VRN11' 임상 1상 결과 공개 ↗뉴스핌 · Published 2026-10-27 · Sources checked 2026-11-18 · Original unavailable
  4. 보로노이, ESMO 2026서 'VRN10' 임상 1상 결과 발표 ↗뉴스핌 · Published 2026-10-26 · Sources checked 2026-11-18 · Original unavailable
  5. Careers ↗보로노이 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable